Effect of Cyclosporine on Expression of MIC in Human Hepatocytes

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2231-2233

  He, Y ^a   Li, S ^a   Feng, L ^a   Cheng, F ^a   Ye, Z ^a   Li, Y ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYCLOSPORIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 B; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONFOCAL MICROSCOPY; DOSE RESPONSE; DRUG DETERMINATION; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; LASER MICROSCOPY; LIVER CELL; LIVER ISCHEMIA; LIVER PERFUSION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; STRESS; SURVIVAL RATE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CELLS, CULTURED; CYCLOSPORINE; GENE EXPRESSION REGULATION; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KINETICS;

EID: 33846086901     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.080     Document Type: Article

References (11)

1. Bahram S., Bresnahan M., Geraghty D.E., et al. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 91 (1994) 6259
2. Bauer S., Groh V., Wu J., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727
3. Ogita K., Hopkinson K., Nakao M., et al. Stress responses in graft and native intestine after rat heterotopic small bowel transplantation. Transplantation 69 (2000) 2273
4. Flohe S., Speidel N., Flach R., et al. Expression of HSP 70 as a potential prognostic marker for acute rejection in human liver transplantation. Transpl Int 11 (1998) 89
5. Granja C., Moliterno R.A., Ferreira M.S., et al. T-cell autoreactivity to Hsp in human transplantation may involve both proinflammatory and regulatory functions. Hum Immunol 65 (2004) 124
6. Bennett W.M., De Mattos A., Meyer M.M., et al. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 50 (1996) 1089
7. Shihab F.S. Cyclosporine nephropathy. Pathophysiology and clinical impact. Semin Nephrol 16 (1996) 536
8. Bantle J.P., Nath K.A., Sutherland D.E.R., et al. Effects of cyclosporine on renin-angiotensin-aldosterone system and potassium excretion in renal transplant recepients. Arch Intern Med 145 (1985) 505
9. Walker P.D., Das C., and Shnh S.V. Cyclosporin A induced lipid peroxidation in renal cortical mitochondria. Kidney Int 29 (1986) 311
10. Mizutani K., Terasaki P., Rosen A., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5 (2005) 2265
11. Sumitran-Holgersson S., Wilczek H.E., Holgersson J., et al. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 74 (2002) 268